Bingwei Li

665 total citations
47 papers, 512 citations indexed

About

Bingwei Li is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Bingwei Li has authored 47 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Physiology. Recurrent topics in Bingwei Li's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Dietary Effects on Health (5 papers). Bingwei Li is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Dietary Effects on Health (5 papers). Bingwei Li collaborates with scholars based in China and Russia. Bingwei Li's co-authors include Ruijuan Xiu, Xiaochen Yuan, Mingming Liu, Qingbin Wu, Hongwei Li, Bing Wang, Qiuju Zhang, Xiaoyan Zhang, Honggang Zhang and Weiwei Qin and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bingwei Li

42 papers receiving 505 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bingwei Li 181 103 79 76 66 47 512
Qiu-Hua Liang 229 1.3× 104 1.0× 26 0.3× 49 0.6× 84 1.3× 16 557
Binhai Cong 154 0.9× 84 0.8× 61 0.8× 18 0.2× 84 1.3× 23 470
Hong Tan 271 1.5× 63 0.6× 35 0.4× 50 0.7× 76 1.2× 22 621
Gerald Matchett 131 0.7× 53 0.5× 59 0.7× 32 0.4× 75 1.1× 20 646
Agnieszka Siejka 233 1.3× 94 0.9× 48 0.6× 41 0.5× 56 0.8× 47 792
Corry D. Bondi 189 1.0× 32 0.3× 34 0.4× 51 0.7× 71 1.1× 13 482
Hirokazu Matsuki 141 0.8× 140 1.4× 48 0.6× 45 0.6× 63 1.0× 16 711
Zhiping Tang 196 1.1× 60 0.6× 29 0.4× 17 0.2× 47 0.7× 26 513
Demet Tekin 191 1.1× 95 0.9× 121 1.5× 16 0.2× 120 1.8× 30 631
Casilde Sesti 203 1.1× 31 0.3× 59 0.7× 38 0.5× 136 2.1× 18 724

Countries citing papers authored by Bingwei Li

Since Specialization
Citations

This map shows the geographic impact of Bingwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingwei Li more than expected).

Fields of papers citing papers by Bingwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingwei Li. The network helps show where Bingwei Li may publish in the future.

Co-authorship network of co-authors of Bingwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bingwei Li. A scholar is included among the top collaborators of Bingwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingwei Li. Bingwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qingbin, Yuhang Wang, Bingwei Li, et al.. (2025). Research Trends of Hepatic Stellate Cells in Hepatoma: A Bibliometric Analysis. Journal of Cellular and Molecular Medicine. 29(19). e70830–e70830. 1 indexed citations
2.
Zhang, Xiaoyan, Bingwei Li, Xueting Liu, et al.. (2024). Tumor‐Derived Exosomes Promote Tumor Growth Through Modulating Microvascular Hemodynamics in a Human Ovarian Cancer Xenograft Model. Microcirculation. 31(7). e12876–e12876. 2 indexed citations
3.
Li, Bingwei & Jinlu Yu. (2024). Embolization of an arteriovenous malformation using the “pressure cooker” technique in the AICA via a marathon microcatheter: A case report. International Journal of Surgery Case Reports. 120(C). 109905–109905.
4.
Wang, Bing, Yuan Li, Mengting Xu, et al.. (2024). Navigating the Landscape of Coronary Microvascular Research: Trends, Triumphs, and Challenges Ahead. Reviews in Cardiovascular Medicine. 25(8). 288–288. 5 indexed citations
5.
6.
Li, Bingwei, et al.. (2024). Characteristics of Inflammatory and Normal Endothelial Exosomes on Endothelial Function and the Development of Hypertension. Inflammation. 47(4). 1156–1169. 1 indexed citations
7.
Ling, Hao, Mengting Xu, Bing Wang, et al.. (2023). Global trend and future landscape of coronary microcirculation: A bibliometric and visualized analysis from 1990 to 2021. Heliyon. 9(4). e14894–e14894.
8.
Xu, Mengting, Bing Wang, Bingwei Li, et al.. (2023). Global trend and future landscape of intestinal microcirculation research from 2000 to 2021: A scientometric study. World Journal of Gastroenterology. 29(9). 1523–1535. 2 indexed citations
9.
Liu, Xueting, Bingwei Li, Xiaojie Yang, et al.. (2022). Sodium Pentobarbital Suppresses Breast Cancer Cell Growth Partly via Normalizing Microcirculatory Hemodynamics and Oxygenation in Tumors. Journal of Pharmacology and Experimental Therapeutics. 382(1). 11–20. 4 indexed citations
10.
Li, Yuan, Bingwei Li, Bing Wang, et al.. (2021). Integrated pancreatic microcirculatory profiles of streptozotocin‐induced and insulin‐administrated type 1 diabetes mellitus. Microcirculation. 28(5). e12691–e12691. 3 indexed citations
11.
Wang, Bing, Yuan Li, Bingwei Li, et al.. (2021). Lymphatic microcirculation profile in the progression of hypertension in spontaneously hypertensive rats. Microcirculation. 29(6-7). e12724–e12724. 5 indexed citations
12.
Li, Bingwei, Xiaochen Yuan, Mingming Liu, et al.. (2021). Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA. International Journal of Biological Sciences. 17(11). 2884–2898. 8 indexed citations
13.
Wu, Qingbin, Xiaochen Yuan, Bingwei Li, et al.. (2020). <p>Salvianolic Acid Alleviated Blood–Brain Barrier Permeability in Spontaneously Hypertensive Rats by Inhibiting Apoptosis in Pericytes via P53 and the Ras/Raf/MEK/ERK Pathway</p>. Drug Design Development and Therapy. Volume 14. 1523–1534. 15 indexed citations
14.
Li, Bingwei, Qiuju Zhang, Honggang Zhang, Chunxiao Wang, & Ruijuan Xiu. (2020). Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension. Bioscience Reports. 40(5). 5 indexed citations
15.
Zhao, Hongwei, et al.. (2020). Diagnostic value of miR-186-5p for carotid artery stenosis and its predictive significance for future cerebral ischemic event. Diagnostic Pathology. 15(1). 101–101. 11 indexed citations
16.
Wu, Qingbin, Xiaochen Yuan, Bingwei Li, et al.. (2020). Differential miRNA expression analysis of extracellular vesicles from brain microvascular pericytes in spontaneous hypertensive rats. Biotechnology Letters. 42(3). 389–401. 14 indexed citations
17.
Wu, Qingbin, Xiaochen Yuan, Bingwei Li, et al.. (2019). Integrated exosomal miRNA and transcriptome analysis of brain microvascular endothelial cells in spontaneously hypertensive rats. Hypertension Research. 43(2). 90–98. 7 indexed citations
18.
Li, Bingwei, et al.. (2018). Effects of tumor necrosis factor‐α‐induced exosomes on the endothelial cellular behavior, metabolism and bioenergetics. Microcirculation. 26(1). e12515–e12515. 6 indexed citations
19.
Liu, Mingming, Xiaoyan Zhang, Bing Wang, et al.. (2017). Functional status of microvascular vasomotion is impaired in spontaneously hypertensive rat. Scientific Reports. 7(1). 17080–17080. 11 indexed citations
20.
Wang, Yubo, et al.. (2015). Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines. Experimental and Therapeutic Medicine. 10(1). 316–322. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026